pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
NOVOLIN R
NOVOLIN R (HUMAN INSULIN)
Novo Nordisk Inc
0
catalysts
Preclinical
NOVS-100
Obesity
Celloram Inc
0
catalysts
NOXAFIL
NOXAFIL (POSACONAZOLE)
Merck Sharp & Dohme LLC
0
catalysts
NOXAFIL POWDERMIX KIT
NOXAFIL POWDERMIX KIT (POSACONAZOLE)
neutropenia
Lanosterol 14-alpha demethylase
$MRK
Merck & Co., Inc.
← prev
page 131 of 271
next →
131
Pain
89
Neurology
1
0
catalysts
pre_registration
NP-001
Amyotrophic Lateral Sclerosis
Neuvivo Inc
0
catalysts
Phase 3
NP-028
Coronavirus Disease 2019 (COVID-19)
$EBS
Emergent BioSolutions Inc.
0
catalysts
Phase 1
NP-10679
Subarachnoid Hemorrhage
NeurOp Inc
0
catalysts
Phase 2
NP-213
Novexatin
Onychomycosis (Tinea Unguium)
Novabiotics Ltd
0
catalysts
Phase 1
NP-3
Nephropathic Cystinosis
Nacuity Pharmaceuticals Inc
0
catalysts
Preclinical
NP-4
Cystinosis
Nacuity Pharmaceuticals Inc
0
catalysts
Preclinical
NP-6A
Cardiomyopathy
Novopyxis Inc
0
catalysts
Preclinical
NP-855
Neuroblastoma
NanoPharmaceuticals LLC
0
catalysts
Preclinical
NPC-31
Neurodegenerative Diseases
Nobelpharma Co Ltd
0
catalysts
Phase 3
NPG-2044
Ovarian Cancer
Novita Pharmaceuticals Inc
0
catalysts
Phase 1
NPX-887
Adenocarcinoma Of The Gastroesophageal Junction
NextPoint Therapeutics Inc
0
catalysts
Preclinical
NRDN-101
Type 1 Diabetes (Juvenile Diabetes)
Neurodon LLC
0
catalysts
Phase 1
NRL-1049
Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hema…
Neurelis Inc
0
catalysts
Phase 1
NRS-033
Opium (Opioid) Addiction
Nirsum Laboratories Inc
0
catalysts
Phase 2
NRT-023
Post Partum Depression (Maternal Depression / Postnatal Depression)
Nanjing Noratech Pharmaceutical Inc
0
catalysts
Phase 3
NRTX-1001
Epilepsy
Neurona Therapeutics Inc
0
catalysts
Preclinical
NS-002
Hyperammonemia
Nano Scrips
0
catalysts
Phase 2
NS-050
Duchenne Muscular Dystrophy
NS Pharma Inc
0
catalysts
Preclinical
NS-051
Duchenne Muscular Dystrophy
NS Pharma Inc
0
catalysts
Phase 2
NS-229
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
Nippon Shinyaku Co Ltd
0
catalysts
Phase 2
NT-101
Wet (Neovascular / Exudative) Macular Degeneration
NexThera Co Ltd
0
catalysts
Preclinical
NT-102
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Neuroene Therapeutics LLC
0
catalysts
Phase 2
NT-219
Metastatic Colorectal Cancer
$PPBT
PURPLE BIOTECH LTD.
0
catalysts
Phase 2
NTCDM-3
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Destiny Pharma Ltd
0
catalysts
Preclinical
NTG-101
Degenerative Disc Disease
Notogen Inc
0
catalysts
Preclinical
NTM-004
Pain
Neumentum Inc
0
catalysts
